Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Phibro Animal Health (PAHC) Operating Expenses (2016 - 2025)

Phibro Animal Health has reported Operating Expenses over the past 14 years, most recently at $82.5 million for Q4 2025.

  • Quarterly results put Operating Expenses at $82.5 million for Q4 2025, down 3.09% from a year ago — trailing twelve months through Dec 2025 was $298.6 million (up 5.61% YoY), and the annual figure for FY2025 was $293.3 million, up 12.72%.
  • Operating Expenses for Q4 2025 was $82.5 million at Phibro Animal Health, up from $68.8 million in the prior quarter.
  • Over the last five years, Operating Expenses for PAHC hit a ceiling of $85.2 million in Q4 2024 and a floor of $48.4 million in Q4 2021.
  • Median Operating Expenses over the past 5 years was $60.6 million (2022), compared with a mean of $62.3 million.
  • Biggest five-year swings in Operating Expenses: decreased 4.75% in 2023 and later skyrocketed 35.34% in 2024.
  • Phibro Animal Health's Operating Expenses stood at $48.4 million in 2021, then grew by 27.21% to $61.5 million in 2022, then grew by 2.23% to $62.9 million in 2023, then skyrocketed by 35.34% to $85.2 million in 2024, then decreased by 3.09% to $82.5 million in 2025.
  • The last three reported values for Operating Expenses were $82.5 million (Q4 2025), $68.8 million (Q3 2025), and $76.3 million (Q2 2025) per Business Quant data.